Erectile dysfunction and low testosterone: Treating both at once

Yes, a licensed provider can evaluate erectile dysfunction and low testosterone in one remote care plan where legally permitted, and a combined workup is usually smarter than separate visits. That matters because testosterone deficiency is considered alongside persistent symptoms and repeat morning levels, often below about 350 ng/dL total or 100 pg/mL free at Veedma, while most erectile dysfunction is still driven primarily by blood vessel problems rather than hormones alone.^{[1] [2] [3]}

Key takeaways

• AUA guidance recommends checking morning testosterone in men with erectile dysfunction, but testosterone deficiency is diagnosed only when symptoms line up with repeat low morning levels, not after one borderline lab result.^{[1] [2] [3]}
• Erectile dysfunction is an early cardiovascular risk marker, and symptoms can precede overt coronary disease by years, which is why blood pressure, lipids, and glucose belong in the same workup.^{[1] [4] [5]}
• A 2017 meta analysis estimated erectile dysfunction prevalence at 66.3% in men with type 2 diabetes, which is one reason metabolic screening matters as much as hormone testing.^[6]
• Testosterone is not a universal erection fix. In a randomized trial of 140 men with erectile dysfunction and low testosterone, adding testosterone to a PDE5 inhibitor did not significantly improve erectile function.^[7]
• At Veedma, LH and FSH are included with the initial morning hormone panel, and repeat low testosterone together with persistent symptoms is interpreted to classify primary versus secondary hypogonadism.

Why low testosterone and erectile dysfunction overlap, but are not the same

Low testosterone and erectile dysfunction often travel together, but they are not the same diagnosis.

Testosterone mainly supports libido, spontaneous erections, nitric oxide signaling, and long term penile tissue health, while the actual mechanics of an erection depend mostly on healthy arteries, smooth muscle, nerves, and intact endothelial function. According to the AUA erectile dysfunction guideline, erectile dysfunction is often a vascular problem, which is why a man can have normal testosterone and still have clear erectile dysfunction.^{[1] [3]}

The reverse is also true. A man can have low testosterone with lower sex drive, fatigue, and fewer morning erections, yet still be able to get usable erections, especially early in the course. In the Testosterone Trials, testosterone treatment improved sexual desire more consistently than it transformed erection quality, which helps answer the common search question, “does low testosterone cause erectile dysfunction.” Sometimes it contributes. Often it does not explain the whole picture.^{[8] [9]}

How a combined workup and treatment plan works

A combined telehealth erectile dysfunction low testosterone visit should evaluate vascular risk, hormone status, and fertility goals in the same plan.

Hormones are one piece of erection biology

Testosterone helps maintain libido and penile nitric oxide activity, but erection quality still depends on arterial inflow and endothelial health. Endothelium means the thin inner lining of blood vessels, and when it is impaired by diabetes, smoking, hypertension, or dyslipidemia, erections weaken even if testosterone is normal.^{[1] [4]}

Erectile dysfunction can be an early vascular warning sign

According to the AUA erectile dysfunction guideline, men with erectile dysfunction should be counseled that it is a risk marker for underlying cardiovascular disease and other health conditions. In the COBRA trial and later cohort meta analyses, erectile symptoms often appeared years before angina or a cardiovascular event, especially in men with chronic coronary syndromes.^{[1] [4] [5]}

A proper workup measures more than testosterone

Hypogonadism means persistent symptoms plus consistently low testosterone, not a single bad lab day, and both the AUA testosterone deficiency guideline and the Endocrine Society recommend repeat morning testing. Gonadotropins means the pituitary signals LH and FSH, and they must be measured alongside total and free testosterone because high LH with low testosterone points to primary hypogonadism, while low or normal LH with low testosterone suggests secondary hypogonadism.^{[2] [3] [9]}

At Veedma, this workup is designed around morning blood draws from 07:00 to 11:00, total testosterone by LC-MS/MS, and free testosterone measured directly with Equilibrium Dialysis and LC-MS/MS. The panel also includes LH, FSH, estradiol, CBC, Comprehensive Metabolic Panel, vitamin D, PSA for men age 40 and older, and insulin when BMI is above 25, with lipids, prolactin, and TSH added when clinically indicated. When symptoms persist and total testosterone is below 350 ng/dL or free testosterone is below 100 pg/mL, Veedma interprets those results together with LH, FSH, and symptoms to classify primary versus secondary hypogonadism and guide treatment discussion.

Raising testosterone alone often falls short

The AUA guideline recommends PDE5 inhibitors as first line therapy for most men with erectile dysfunction because they target penile blood flow directly. Evidence that testosterone meaningfully improves erections in men whose levels are already normal is weak, and a randomized trial found that adding testosterone to a PDE5 inhibitor did not significantly improve erectile function in men with erectile dysfunction and low testosterone.^{[1] [7] [8]}

A combined oral plan treats the vascular side and the hormone side separately

A combined oral plan works because the two jobs are different. A PDE5 inhibitor such as tadalafil targets the blood flow side of erectile dysfunction, while Enclomiphene is used by Veedma as a first line oral option for secondary or functional hypogonadism because it keeps the body’s own testosterone production active and helps preserve spermatogenesis and fertility. Enclomiphene is not FDA approved. The reason LH and FSH matter so much is simple: if LH is already high and testosterone is low, the testes are already being pushed hard, so Enclomiphene is unlikely to solve the problem; if LH is low or normal, especially below 8 mIU/mL, the axis may still be recruitable.^{[2] [3]}

Conditions that commonly sit behind both problems

Cardiometabolic disease is the main shared ground between erectile dysfunction and testosterone problems.

Type 2 diabetes is the clearest example. A 2017 meta analysis of 145 studies estimated erectile dysfunction prevalence at 66.3% in men with type 2 diabetes and 52.5% across all diabetes, which reflects the combined effects of vascular damage, neuropathy, inflammation, and metabolic stress. Obesity and metabolic syndrome can also suppress the hypothalamic pituitary gonadal axis and lower testosterone while damaging endothelial function at the same time.^[6]

Hypertension, abnormal lipids, smoking, and established cardiovascular disease belong in the same conversation. According to the AUA erectile dysfunction guideline, erectile symptoms are not just a bedroom issue. They can be an early marker of systemic vascular disease. That is why a real erectile dysfunction and testosterone workup checks blood pressure, glucose, and lipids rather than stopping at hormones.

Symptoms and signals to watch for

The pattern of symptoms often tells you whether low testosterone, vascular erectile dysfunction, or both are in play.

• Your interest in sex is clearly lower for weeks or months, not just after one stressful day, and you also notice fewer spontaneous morning erections.
• You can get partly hard but not rigid enough for penetration, or you lose firmness within minutes even though desire is still there.
• You still want sex, but erections have become less reliable after heavy meals, alcohol, poor sleep, or under pressure. That pattern often points to blood flow or stress, not hormones alone.
• You feel more tired, recover slower from workouts, and notice more body fat or lower gym performance alongside lower libido. That cluster fits low testosterone better than erectile dysfunction alone.
• You have diabetes, high blood pressure, high cholesterol, obesity, or you smoke. Those increase the odds that erection problems are at least partly vascular.
• You are trying to preserve fertility. That changes the treatment discussion immediately, because some testosterone raising strategies can suppress sperm production.
• Stop self managing and get seen promptly if the problem starts suddenly, erections become painful, or erectile symptoms show up with chest discomfort, fainting, or new shortness of breath.

Myth vs fact

Myth: Low testosterone always causes erectile dysfunction

Fact: Low testosterone can reduce desire and contribute to weaker erections over time, but most erectile dysfunction is vascular or endothelial in origin. A man can have normal testosterone and significant erectile dysfunction, and another man can have low testosterone with only mild erection changes.

Myth: Treating testosterone alone usually fixes erections

Fact: Not usually. Guidelines place PDE5 inhibitors first for most men with erectile dysfunction because they directly address blood flow, and testosterone helps most when true hypogonadism is present rather than when levels are already normal.

Myth: One low testosterone result means you have hypogonadism

Fact: Male hypogonadism is a clinical syndrome, not a single lab number. Symptoms and repeat morning biochemical evidence both have to be present, and LH plus FSH are needed to classify primary versus secondary hypogonadism.

Myth: Telehealth cannot handle erectile dysfunction and low testosterone together

Fact: For men searching telehealth erectile dysfunction low testosterone care, one licensed provider can often coordinate the same evidence based history, symptom review, repeat morning labs, metabolic screening, and medication plan in one pathway, then direct an in person evaluation if red flags appear.

What to do if you think both are in play

The right next step is a structured three part plan, not trial and error with internet supplements.

1. Step 1: Map the pattern before you treat anything. Write down whether the main issue is low desire, weaker morning erections, trouble getting firm, trouble staying firm, or all of the above. Also note alcohol use, sleep, medications, chest symptoms, and whether fertility matters right now.
2. Step 2: Get a combined workup. That means repeat morning total testosterone and free testosterone, LH and FSH to classify the hormone problem, plus CBC, Comprehensive Metabolic Panel, blood pressure, lipids, and glucose based metabolic screening. If the problem started suddenly, is painful, or comes with chest symptoms or new shortness of breath, skip self management and get urgent in person care.
3. Step 3: Match treatment to the cause. When the issue is mainly vascular, a PDE5 inhibitor is usually the core treatment. When persistent symptoms line up with secondary or functional hypogonadism, Enclomiphene may be the first line hormone option because it keeps endogenous production active and preserves fertility potential. When both problems are present, a combined oral plan can make more sense than treating each in isolation.

Veedma offers a thorough diagnostic workup with an advanced lab panel using LC-MS/MS, or a review of existing recent blood work rather than automatic repeat testing. Licensed providers build individualized plans with Enclomiphene as the first line hormone option, and with the Enclomiphene plus tadalafil combination tablet when erection or urinary symptoms are also present. Monitoring continues after the first month and then every 6 months so the protocol can be adjusted as labs and symptoms change. If you are unsure whether hormones are part of your picture, Veedma offers a free symptom check at /free-check.

Bottom line

Yes, erectile dysfunction and low testosterone can be treated together in one plan where legally permitted, but they should never be treated as the same thing. Most erectile dysfunction is driven by vascular issues, low testosterone mainly affects desire and long term tissue support, and testosterone alone often will not fully restore erections.

References

1. Pantazis A, Franco I, Gitlin J. Erectile Dysfunction in Adolescents and Young Adults. Current urology reports. 2024;25:225-232. PMID: 38922362
2. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. The Journal of urology. 2018;200:423-432. PMID: 29601923
3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2018;103:1715-1744. PMID: 29562364
4. Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, et al. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circulation. Cardiovascular quality and outcomes. 2013;6:99-109. PMID: 23300267
5. Faselis C, Katsimardou A, Imprialos K, et al. Microvascular Complications of Type 2 Diabetes Mellitus. Current vascular pharmacology. 2020;18:117-124. PMID: 31057114
6. Bucher J, Christ ER. [Not Available]. Therapeutische Umschau. Revue therapeutique. 2014;71:221-7. PMID: 24670603
7. Spitzer M, Basaria S, Travison TG, et al. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Annals of internal medicine. 2012;157:681-91. PMID: 23165659
8. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. The New England journal of medicine. 2016;374:611-24. PMID: 26886521
9. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. The New England journal of medicine. 2010;363:123-35. PMID: 20554979